Sensorion SA (ALSEN.PA)

EUR 0.46

(15.0%)

Long Term Debt Summary of Sensorion SA

  • Sensorion SA's latest annual long term debt in 2023 was 1.24 Million EUR , down -35.93% from previous year.
  • Sensorion SA's latest quarterly long term debt in 2024 Q2 was 890 Thousand EUR , down 0.0% from previous quarter.
  • Sensorion SA reported annual long term debt of 1.93 Million EUR in 2022, down -26.51% from previous year.
  • Sensorion SA reported annual long term debt of 2.63 Million EUR in 2021, down -12.31% from previous year.
  • Sensorion SA reported quarterly long term debt of 1.24 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Sensorion SA reported quarterly long term debt of 1.58 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Sensorion SA (2023 - 2011)

Historical Annual Long Term Debt of Sensorion SA (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 1.24 Million EUR -35.93%
2022 1.93 Million EUR -26.51%
2021 2.63 Million EUR -12.31%
2020 3 Million EUR 339.36%
2019 684.08 Thousand EUR 0.0%
2018 - EUR -100.0%
2017 1.84 Million EUR 85.23%
2016 998.52 Thousand EUR 35.21%
2015 738.52 Thousand EUR 22.59%
2014 602.45 Thousand EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%
2011 - EUR 0.0%

Peer Long Term Debt Comparison of Sensorion SA

Name Long Term Debt Long Term Debt Difference
ABIONYX Pharma SA 1.1 Million EUR -12.708%
ABIVAX Société Anonyme 44.69 Million EUR 97.224%
Adocia SA 4.54 Million EUR 72.667%
Aelis Farma SA 2.04 Million EUR 39.409%
Biophytis S.A. 3.11 Million EUR 60.112%
Advicenne S.A. 15.89 Million EUR 92.194%
genOway Société anonyme 5.51 Million EUR 77.517%
IntegraGen SA 642.28 Thousand EUR -93.204%
Medesis Pharma S.A. 1.2 Million EUR -3.409%
Neovacs S.A. 650 Thousand EUR -90.909%
NFL Biosciences SA 39.2 Thousand EUR -3065.347%
Plant Advanced Technologies SA 4.35 Million EUR 71.516%
Quantum Genomics Société Anonyme 1.96 Million EUR 36.699%
Theranexus Société Anonyme 2.46 Million EUR 49.571%
TME Pharma N.V. - EUR -Infinity%
Valbiotis SA 3.89 Million EUR 68.165%
TheraVet SA 1 Million EUR -24.017%
Valerio Therapeutics Société anonyme 6.9 Million EUR 82.031%
DBV Technologies S.A. 4.52 Million USD 72.583%
Genfit S.A. 62.25 Million EUR 98.007%
GeNeuro SA 6.49 Million EUR 80.886%
Innate Pharma S.A. 30.6 Million EUR 95.946%
Inventiva S.A. 25.61 Million EUR 95.156%
MaaT Pharma SA 5.42 Million EUR 77.126%
MedinCell S.A. 52.8 Million EUR 97.65%
Nanobiotix S.A. 41.66 Million EUR 97.021%
OSE Immunotherapeutics SA 35.5 Million EUR 96.505%
Poxel S.A. 40.14 Million EUR 96.909%
GenSight Biologics S.A. 1.04 Million EUR -18.408%
Transgene SA 17 Thousand EUR -7199.476%
Valneva SE 132.76 Million EUR 99.065%